Assignee
AB SCIENCE
FR·16 granted patents·27 pending applications·76 citations·filing 2002–2022
Top patents by PatentIndex Score
43 records- 0192US10092564B2Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulationAB SCIENCE·Filed 2017·Granted Oct 9, 2018·11 cites·20 claims
- 0288US7423055B22-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseasesAB SCIENCE·Filed 2003·Granted Sep 9, 2008·29 cites·30 claims
- 0387US7718676B22-aminoaryloxazole compounds as tyrosine kinase inhibitorsAB SCIENCE·Filed 2004·Granted May 18, 2010·31 cites·17 claims
- 0473US8993573B22-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsAB SCIENCE·Filed 2013·Granted Mar 31, 2015·1 cites·10 claims
- 0564US7727731B2Potent, selective and non toxic c-kit inhibitorsAB SCIENCE·Filed 2002·Granted Jun 1, 2010·2 cites·24 claims
- 0662US7700610B2Use of tyrosine kinase inhibitors for treating allergic diseasesAB SCIENCE·Filed 2002·Granted Apr 20, 2010·1 cites·2 claims
- 0762US7678805B2Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)AB SCIENCE·Filed 2002·Granted Mar 16, 2010·1 cites·4 claims
- 0860US2008255141A12-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsAB SCIENCE·Filed 2007·Application pending·0 cites
- 0958US2009082360A1Use of tyrosine kinase inhibitors for treating CNS disordersAB SCIENCE·Filed 2008·Application pending·0 cites
- 1057US8940894B2Aminothiazole compounds as kinase inhibitors and methods of using the sameAB SCIENCE·Filed 2013·Granted Jan 27, 2015·0 cites·3 claims
- 1156US2023321081A1Masitinib for the treatment of castrate-resistant prostate cancerAB SCIENCE·Filed 2022·Application pending·0 cites
- 1254US10238649B2Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factorsAB SCIENCE·Filed 2013·Granted Mar 26, 2019·0 cites·11 claims
- 1354US2005239852A12-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitorsAB SCIENCE·Filed 2003·Application pending·0 cites
- 1454US2024058328A1Masitinib for the treatment of alzheimer's diseaseAB SCIENCE·Filed 2021·Application pending·0 cites
- 1552US2023023935A1Use of masitinib for the treatment of eosinophilic asthmaAB SCIENCE·Filed 2020·Application pending·0 cites
- 1652US2016263110A1Use of masitinib for treatment of amyotrophic lateral sclerosisAB SCIENCE·Filed 2014·Application pending·0 cites
- 1751US2017196853A1Use of an inhibitor of kinase activity, particularly masitinib, for treatment of prostate cancerAB SCIENCE·Filed 2014·Application pending·0 cites
- 1850US2023089715A1Masitinib for the treatment of a multiple sclerosis patient subpopulationAB SCIENCE·Filed 2021·Application pending·0 cites
- 1949US2016244845A1Method for determining the prognosis of pancreatic cancerAB SCIENCE·Filed 2014·Application pending·0 cites
- 2049US2008242704A1Substituted Oxazole Derivatives and their Use as Tyrosine Kinase InhibitorsAB SCIENCE·Filed 2006·Application pending·0 cites
- 2147US2007032521A1Use of c-kit inhibitors for treating type II diabetesAB SCIENCE·Filed 2004·Application pending·0 cites
- 2246US2023226043A1Use of masitinib for the treatment of coronavirus disease 2019 (covid-19)AB SCIENCE·Filed 2021·Application pending·0 cites
- 2346US2008025916A1Tailored Treatment Suitable for Different Forms of MastocytosisAB SCIENCE·Filed 2004·Application pending·0 cites
- 2446US2007191267A1Use of tyrosine kinase inhibitors for treating cerebral ischemiaAB SCIENCE·Filed 2004·Application pending·0 cites
- 2545US12472164B2Masitinib for the treatment of sickle cell diseaseAB SCIENCE·Filed 2020·Granted Nov 18, 2025·0 cites·17 claims
- 2644US10045978B2Treatment of mastocytosis with masitinibAB SCIENCE·Filed 2015·Granted Aug 14, 2018·0 cites·18 claims
- 2744US2015290235A1Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infectionsAB SCIENCE·Filed 2013·Application pending·0 cites
- 2844US2008207572A1Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple MyelomaAB SCIENCE·Filed 2006·Application pending·0 cites
- 2943US7741335B2Use of tyrosine kinase inhibitors for treating inflammatory diseasesAB SCIENCE·Filed 2002·Granted Jun 22, 2010·0 cites·1 claims
- 3042US2016128999A1Masitinib for treating hepatic cancerAB SCIENCE·Filed 2015·Application pending·0 cites
- 3141US10202370B2Benzimidazole derivatives as selective proteine kinase inhibitorsAB SCIENCE·Filed 2014·Granted Feb 12, 2019·0 cites·8 claims
- 3241US2008039466A12-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase InhibitorsAB SCIENCE·Filed 2005·Application pending·0 cites
- 3341US2017119760A1Use of masitinib for the treatment of progressive supranuclear palsyAB SCIENCE·Filed 2016·Application pending·0 cites
- 3441US2016022671A1Treatment of mastocytosis with masitinibAB SCIENCE·Filed 2015·Application pending·0 cites
- 3541US2018311236A1Use of masitinib and other mast cell inhibitors for treatment of parkinson's diseaseAB SCIENCE·Filed 2016·Application pending·0 cites
- 3641US2007225293A1Use of C-Kit Inhibitors for Treating FibrosisAB SCIENCE·Filed 2005·Application pending·0 cites
- 3741US2008146585A1Use Of C-Kit Inhibitors For Treating Inflammatory Muscle Disorders Including Myositis And Muscular DystrophyAB SCIENCE·Filed 2005·Application pending·0 cites
- 3840US2017020867A1Use of masitinib for the treatment of crohn's diseaseAB SCIENCE·Filed 2016·Application pending·0 cites
- 3939US2017340629A1Masitinib combination for use in treating breast cancerAB SCIENCE·Filed 2015·Application pending·0 cites
- 4039US2016175302A1Masitinib for treating gastric cancerAB SCIENCE·Filed 2015·Application pending·0 cites
- 4133US10392373B2Oxazole derivatives that inhibit SykAB SCIENCE·Filed 2016·Granted Aug 27, 2019·0 cites·15 claims
- 4232US10570122B2Compounds with anti-tumoral activityAB SCIENCE·Filed 2016·Granted Feb 25, 2020·0 cites·19 claims
- 4329US10053455B2Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitorsAB SCIENCE·Filed 2015·Granted Aug 21, 2018·0 cites·19 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →